SPONSOR
University of Alabama at Birmingham
Total Trials
31
Recruiting
31
Phases
Phase 2, Phase 1, Phase 2, Phase 4, EARLY_Phase 1, Phase 1
Conditions studied: Breast NeoplasmPainGender IdentityAcute Kidney InjurySickle Cell DiseaseCognitive ImpairmentAdolescent BehaviorSelf EfficacyHealth-Related BehaviorCoping Skills
University of Alabama at Birmingham is a clinical research sponsor with 31 registered studies on ClinicalTrials.gov, of which 31 are actively recruiting participants. Research covers conditions including Breast Neoplasm, Pain, Gender Identity, Acute Kidney Injury.
The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Alabama at Birmingham
How many clinical trials has University of Alabama at Birmingham sponsored?
ClinicalMetric currently tracks 31 clinical trials sponsored by University of Alabama at Birmingham, of which 31 are actively recruiting participants. These trials cover conditions including Breast Neoplasm, Pain, Gender Identity. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Alabama at Birmingham research focus on?
University of Alabama at Birmingham clinical trials span Breast Neoplasm, Pain, Gender Identity, Acute Kidney Injury, Sickle Cell Disease, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Alabama at Birmingham clinical trial?
To participate in a University of Alabama at Birmingham trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Alabama at Birmingham trials with current recruitment status updated daily.
Clinical Trials by University of Alabama at Birmingham
NCT06294574
Recruiting
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
Breast Neoplasm
NCT05787470
Recruiting
State of Hormones Impact Nociceptive Expression
Pain
NCT04144894
Recruiting
The Biosonographic Index
Acute Kidney Injury
NCT05336201 Phase 2
Recruiting
Cognitive Remediation Intervention to Prepare for Transition of Care
Sickle Cell Disease
NCT04396002
Recruiting
Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
Primary Open Angle Glaucoma
NCT04920136
Recruiting
Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix
Gingival Recession
NCT05708716
Recruiting
Diet and Cognitive Training in Hematologic Cancer Survivors
Cognitive Impairment
NCT05384145
Recruiting
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
HIV
NCT07161726 Phase 1, Phase 2
Recruiting
Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial
Mobility Disability
NCT05193552 Phase 4
Recruiting
Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease
Common Variable Immunodeficiency
NCT07051655
Recruiting
The Effects of Exogenous Ketones on Cognitive Function
Placebo - Control
NCT06326476 EARLY_Phase 1
Recruiting
Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
Hidradenitis Suppurativa
NCT07223086
Recruiting
Use of Tinted Contact Lenses for Concussion-Related Light Sensitivity
Concussion, Mild
NCT04362644 Phase 1
Recruiting
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
NCT07025421
Recruiting
The ARISE Study - Use of Vertical Positioning
Acute Respiratory Distress Syndrome
NCT05606432
Recruiting
Cardiometabolic Health Intervention Using Movement-to-Music Exercise
Cardiometabolic Risk Factors in Adult Wheelchair Users
NCT05676476
Recruiting
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
Preeclampsia
NCT05253131 Phase 2
Recruiting
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
MPNST
NCT07224529 Phase 4
Recruiting
Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction
Meibomian Gland Dysfunction (MGD)
NCT06570954
Recruiting
Retraining and Control Therapy (ReACT)- Adults
Convulsion, Non-Epileptic
NCT06966258
Recruiting
Inspire HER: Inspiring the Heart and Emotions for Radical Health
Cardiovascular-kidney-metabolic Syndrome
NCT06356558
Recruiting
Adapting Enhanced Recovery Programs for Low Health Literacy Patients
Surgery
NCT03094026
Recruiting
Cognitive Training Intervention and Attitudes Towards Genetics
Cognitive Impairment
NCT05664841 Phase 2
Recruiting
The Impact of a Virtual Magic Trick Training Program
Autism
NCT05556928
Recruiting
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
Multiple Myeloma
NCT06734611
Recruiting
Folic Acid Salt Study (FISFA Zambia)
Folate Deficiency
NCT05785884
Recruiting
Diet Interventions: Remitted and Evaluated as Complementary Treatments for Pain
Knee Osteoarthritis
NCT04606914 Phase 2
Recruiting
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Ovarian Cancer
NCT06370481
Recruiting
HIV, Equity, and Addiction Training (HEAT) Program
Substance Use Disorders
NCT07104656
Recruiting
Bony Overlap Following Use of the Inferior Border Saw for the 'Low and Short' Sagittal Split: A Split-Mouth Study
Mandibular Surgery
NCT06104280
Recruiting
Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment
Opioid Use Disorder
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology